| Human C3 deficiency associated with impairments in dendritic cell differentiation, memory B cells, and regulatory T cells A Ghannam, M Pernollet, JL Fauquert, N Monnier, D Ponard, MB Villiers, ... The Journal of Immunology 181 (7), 5158-5166, 2008 | 125 | 2008 |
| SERPING1 mutation update: Mutation spectrum and C1 Inhibitor phenotypes D Ponard, C Gaboriaud, D Charignon, A Ghannam, IGA Wagenaar‐Bos, ... Human mutation 41 (1), 38-57, 2020 | 87 | 2020 |
| Human complement C3 deficiency: Th1 induction requires T cell-derived complement C3a and CD46 activation A Ghannam, JL Fauquert, C Thomas, C Kemper, C Drouet Molecular immunology 58 (1), 98-107, 2014 | 83 | 2014 |
| Enzymatic assays for the diagnosis of bradykinin-dependent angioedema F Defendi, D Charignon, A Ghannam, R Baroso, F Csopaki, ... PLoS One 8 (8), e70140, 2013 | 74 | 2013 |
| Hereditary angioedema with F12 mutation: factors modifying the clinical phenotype D Charignon, A Ghannam, F Defendi, D Ponard, N Monnier, ... Allergy 69 (12), 1659-1665, 2014 | 44 | 2014 |
| Kininogen cleavage assay: diagnostic assistance for kinin-mediated angioedema conditions R Baroso, P Sellier, F Defendi, D Charignon, A Ghannam, M Habib, ... PLoS One 11 (9), e0163958, 2016 | 29 | 2016 |
| SERPING1 Variants and C1-INH Biological Function: A Close Relationship With C1-INH-HAE C Drouet, A López-Lera, A Ghannam, M López-Trascasa, S Cichon, ... Frontiers in allergy 3, 835503, 2022 | 26 | 2022 |
| C1 inhibitor function using contact‐phase proteases as target: evaluation of an innovative assay A Ghannam, P Sellier, F Defendi, B Favier, D Charignon, A López‐Lera, ... Allergy 70 (9), 1103-1111, 2015 | 26 | 2015 |
| Hereditary C1 inhibitor deficiency is associated with high spontaneous amidase activity D Charignon, A Ghannam, D Ponard, C Drouet Molecular Immunology 85, 120-122, 2017 | 17 | 2017 |
| Contact system activation in patients with HAE and normal C1 inhibitor function A Ghannam, F Defendi, D Charignon, F Csopaki, B Favier, M Habib, ... Immunology and Allergy Clinics 33 (4), 513-533, 2013 | 17 | 2013 |
| C1 Inhibitor as a glycoprotein: The influence of polysaccharides on its function and autoantibody target A Ghannam, P Sellier, O Fain, L Martin, D Ponard, C Drouet Molecular Immunology 71, 161-165, 2016 | 13 | 2016 |
| SERPING1 and F12 combined variants in a hereditary angioedema family D Charignon, D Ponard, C de Gennes, C Drouet, A Ghannam Annals of allergy, asthma & immunology: official publication of the American …, 2018 | 10 | 2018 |
| Angioedema: systemic activation process during prodromes S Luyasu, D Charignon, D Ponard, C Drouet, A Ghannam Annals of Allergy, Asthma & Immunology 121 (2), 248-249, 2018 | 10 | 2018 |
| High-density rafts preferentially host the complement activator measles virus F glycoprotein but not the regulators of complement activation A Ghannam, D Hammache, C Matias, M Louwagie, J Garin, D Gerlier Molecular immunology 45 (11), 3036-3044, 2008 | 9 | 2008 |
| Plasminogen glycoforms alteration and activation susceptibility associated with the missense variant p. Lys330Glu in HAE‐PLG patients. F Parsopoulou, D Charignon, M Tengo, F Psarros, C Maas, ... Allergy 75 (8), 2020 | 7 | 2020 |
| C1 Inhibitor C Drouet, D Ponard, A Ghannam The Complement FactsBook, 241-249, 2018 | 7 | 2018 |
| C1 Inhibitor as a glycoprotein: The influence of polysaccharides on its function and autoantibody target, 71 Mol A Ghannam Immunol, 2016 | 6 | 2016 |
| angioedema. D Federica, A Ghannam, D Ponard, C Drouet Annales de dermatologie et de venereologie 142, 163-169, 2015 | 4 | 2015 |
| Abstracts from the 10th C1-inhibitor deficiency workshop AH Schmaier, M Cicardi, A Reshef, D Moldovan, A Mócsai, ... Allergy, Asthma & Clinical Immunology 13, 1-36, 2017 | 2 | 2017 |
| Hereditary kinin-mediated angioedema: current challenges A Ghannam, AE Germenis, C Drouet Austin Intern Med 1 (1), 1002, 2016 | 2 | 2016 |
